What is Zacks Research’s Estimate for MMSI FY2025 Earnings?

Merit Medical Systems, Inc. (NASDAQ:MMSI) – Stock analysts at Zacks Research lowered their FY2025 earnings per share (EPS) estimates for Merit Medical Systems in a report issued on Tuesday, March 18th. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings of $3.67 per share for the year, down from their prior estimate of $3.70. The consensus estimate for Merit Medical Systems’ current full-year earnings is $3.37 per share.

Several other research analysts have also recently issued reports on MMSI. Raymond James increased their price target on Merit Medical Systems from $105.00 to $110.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 31st. Needham & Company LLC lowered their target price on shares of Merit Medical Systems from $122.00 to $116.00 and set a “buy” rating on the stock in a research note on Wednesday, February 26th. Barrington Research dropped their price target on shares of Merit Medical Systems from $115.00 to $111.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 26th. Canaccord Genuity Group decreased their price objective on shares of Merit Medical Systems from $128.00 to $127.00 and set a “buy” rating for the company in a report on Wednesday, February 26th. Finally, Wells Fargo & Company dropped their target price on Merit Medical Systems from $120.00 to $117.00 and set an “overweight” rating on the stock in a report on Wednesday, February 26th. Two analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $110.78.

Merit Medical Systems Stock Up 0.4 %

MMSI opened at $101.68 on Friday. The stock’s 50 day moving average price is $103.93 and its 200 day moving average price is $100.75. The company has a debt-to-equity ratio of 0.57, a current ratio of 5.36 and a quick ratio of 3.82. The stock has a market cap of $5.98 billion, a P/E ratio of 49.84, a P/E/G ratio of 2.34 and a beta of 0.91. Merit Medical Systems has a 12 month low of $70.70 and a 12 month high of $111.45.

Institutional Trading of Merit Medical Systems

A number of hedge funds have recently bought and sold shares of MMSI. Norges Bank acquired a new stake in shares of Merit Medical Systems during the fourth quarter valued at approximately $66,638,000. FMR LLC raised its stake in Merit Medical Systems by 70.1% during the 3rd quarter. FMR LLC now owns 1,577,246 shares of the medical instruments supplier’s stock valued at $155,879,000 after purchasing an additional 649,799 shares during the period. Raymond James Financial Inc. acquired a new stake in Merit Medical Systems during the 4th quarter valued at $48,926,000. Groupama Asset Managment purchased a new stake in shares of Merit Medical Systems in the fourth quarter valued at $38,688,000. Finally, Bryn Mawr Capital Management LLC purchased a new position in shares of Merit Medical Systems during the fourth quarter valued at $36,057,000. 99.66% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, Director Stephen C. Evans sold 5,000 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $105.31, for a total transaction of $526,550.00. Following the sale, the director now directly owns 4,657 shares of the company’s stock, valued at $490,428.67. The trade was a 51.78 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Brian G. Lloyd sold 25,000 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $99.50, for a total value of $2,487,500.00. Following the completion of the transaction, the insider now owns 38,993 shares of the company’s stock, valued at $3,879,803.50. This trade represents a 39.07 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 109,132 shares of company stock worth $11,139,521. Corporate insiders own 3.70% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.